120 related articles for article (PubMed ID: 6137171)
1. Respiratory depressant effects of different doses of midazolam and lack of reversal with naloxone--a double-blind randomized study.
Forster A; Morel D; Bachmann M; Gemperle M
Anesth Analg; 1983 Oct; 62(10):920-4. PubMed ID: 6137171
[TBL] [Abstract][Full Text] [Related]
2. Failure of nalbuphine to antagonize morphine: a double-blind comparison with naloxone.
Bailey PL; Clark NJ; Pace NL; Isern M; Stanley TH
Anesth Analg; 1986 Jun; 65(6):605-11. PubMed ID: 3085551
[TBL] [Abstract][Full Text] [Related]
3. The effects of large-dose flumazenil on midazolam-induced ventilatory depression.
Flögel CM; Ward DS; Wada DR; Ritter JW
Anesth Analg; 1993 Dec; 77(6):1207-14. PubMed ID: 8250314
[TBL] [Abstract][Full Text] [Related]
4. Respiratory depression of intravenous hydroxyzine in man: potency, duration, and lack of reversal by naloxone.
Gabathuler ML; Kaufman RD
Anesth Analg; 1981 Sep; 60(9):634-7. PubMed ID: 7196705
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of two dosages of orally administered midazolam on psychomotor performance in healthy volunteers.
Schaffler K; Klausnitzer W
Arzneimittelforschung; 1989 Mar; 39(3):395-8. PubMed ID: 2757665
[TBL] [Abstract][Full Text] [Related]
6. Effects of a specific benzodiazepine antagonist (RO 15-1788) on cerebral blood flow.
Forster A; Juge O; Louis M; Nahory A
Anesth Analg; 1987 Apr; 66(4):309-13. PubMed ID: 3105357
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of postoperative opioid-induced respiratory depression: nalbuphine versus naloxone.
Bailey PL; Clark NJ; Pace NL; Stanley TH; East KA; van Vreeswijk H; van de Pol P; Clissold MA; Rozendaal W
Anesth Analg; 1987 Nov; 66(11):1109-14. PubMed ID: 3662056
[TBL] [Abstract][Full Text] [Related]
8. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
9. Comparative haemodynamic and respiratory effects of midazolam and flunitrazepam as induction agents in cardiac surgery.
Morel D; Forster A; Gardaz JP; Suter PM; Gemperle M
Arzneimittelforschung; 1981; 31(12a):2264-7. PubMed ID: 6120703
[TBL] [Abstract][Full Text] [Related]
10. Respiratory depression after epidural morphine--an experimental and clinical study.
Rawal N; Wattwil M
Anesth Analg; 1984 Jan; 63(1):8-14. PubMed ID: 6691568
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of the efficacy and tolerance of a benzodiazepine antagonist (Ro 15-1788)].
Rouiller M; Forster A; Gemperle M
Ann Fr Anesth Reanim; 1987; 6(1):1-6. PubMed ID: 3107442
[TBL] [Abstract][Full Text] [Related]
12. Absence of agonist effects of high-dose flumazenil on ventilation and psychometric performance in human volunteers.
Forster A; Crettenand G; Klopfenstein CE; Morel DR
Anesth Analg; 1993 Nov; 77(5):980-4. PubMed ID: 8214737
[TBL] [Abstract][Full Text] [Related]
13. Respiratory effects of intravenous midazolam.
Zacharias M; Hunter KM; Parkinson R
N Z Dent J; 1996 Sep; 92(409):76-9. PubMed ID: 8910727
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the action of naloxone (Narcan) and nalorphine in man.
Aronski A; Kübler A; Majda A; Jakubaszko J
Anaesth Resusc Intensive Ther; 1975; 3(3):221-30. PubMed ID: 1217693
[TBL] [Abstract][Full Text] [Related]
15. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.
Oertel BG; Schneider A; Rohrbacher M; Schmidt H; Tegeder I; Geisslinger G; Lötsch J
Clin Pharmacol Ther; 2007 Jan; 81(1):59-68. PubMed ID: 17186000
[TBL] [Abstract][Full Text] [Related]
16. [A study on the action of naloxone (author's transl)].
Aroński A; Kübler A
Anaesthesist; 1977 Jul; 26(7):354-6. PubMed ID: 889069
[TBL] [Abstract][Full Text] [Related]
17. Effects of various combinations of benzodiazepines with buprenorphine on arterial blood gases in rats.
Pirnay SO; Mégarbane B; Borron SW; Risède P; Monier C; Ricordel I; Baud FJ
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):228-39. PubMed ID: 18684226
[TBL] [Abstract][Full Text] [Related]
18. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
[TBL] [Abstract][Full Text] [Related]
19. Midazolam and flunitrazepam: pharmacokinetics and effects on night time respiration and body movements in the elderly.
Seppälä M; Alihanka J; Himberg JJ; Kanto J; Rajala T; Sourander L
Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):170-6. PubMed ID: 8500918
[TBL] [Abstract][Full Text] [Related]
20. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
